Diquafosol Tetrasodium Ophthalmic Solution, 2%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Diquafosol Tetrasodium Ophthalmic Solution, 2%, covering 2015-01-09 to 2015-01-09. Get the full timeline:
Most recent: Clinical Trial Update: The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) [Phase 3]